NKT Therapeutics, Inc. Obtains $8,000,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c0bc1a17-bf9a-4d08-b128-b8934889e783&Preview=1 -
Date
3/16/2009 -
Company Name
NKT Therapeutics, Inc. -
Mailing Address
233 Needham Street Newton, MA 02464 -
Company Description
NKT Therapeutics, Inc. (the Company) is a biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. NKT cells are a rare but central component of the human immune system which plays a pivotal role in human health and disease. -
Website
http://www.nktrx.com -
Transaction Type
Venture Equity -
Transaction Amount
$8,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
SV Life Sciences -
Venture Investor
MedImmune Ventures
